Piramal Pharma
PPLPHARMA.NS
#3350
Rank
A$5.45 B
Marketcap
$4.14
Share price
-1.11%
Change (1 day)
58.85%
Change (1 year)

Revenue for Piramal Pharma (PPLPHARMA.NS)

Revenue in 2024 (TTM): A$1.60 Billion

According to Piramal Pharma's latest financial reports the company's current revenue (TTM ) is A$1.68 Billion. an increase over the revenue in the year 2023 that were of A$1.37 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Piramal Pharma from 2022 to 2024

Annual revenue

Year Revenue Change
2024 A$1.69 B23.75%
2023 A$1.37 B5.32%
2022 A$1.30 B